Mablink
FranceEntry
2021
Hold
2yr
Exit
2023
Who owns Mablink?
Mablink was owned by Turenne Groupe through Capital Santé 2 (2020 vintage) from 2021 to 2023, exited via Trade Sale. Across its history, Mablink has been through 2 private equity ownership periods, detailed in the timeline below.
Buyer identity available on Pro.
Hand-verified · updated 2026-04-21
Most recent investor
Turenne GroupeCapital Santé 2 · 2020 · Growth
2 ownership periods · full history below
Key facts
HQFrance
SectorBiotech
Key takeaways
- ·Fully exited in 2023.
- ·Average hold across 2 realized cycles: 2 years.
Ownership history
2 ownership periods · co-invest detected
Exited
Last exited in 2023 to .
More from Capital Santé 2
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USTrack Mablink
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Mablink?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Mablink.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue